Respiratory effects of glutamate receptor antagonists in neonate and adult mammals

European Journal of Pharmacology

Volumn 348, Issue 2-3, 1998, Pages 235-246

  Borday, Véronique ^a   Foutz, Arthur S ^a   Nordholm, Lars ^b   Denavit Saubié, Monique ^a  

^a CNRS   (France)

^b NOVO NORDISK A S   (Denmark)

Author keywords

(Cat); (Mouse); Development; Dizocilpine; NBQX (2,3 dihydroxy 6 nitro 7 sulfamoylbenzo(F)quinoxaline); Neonate; Respiration

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST;

ANESTHESIA; ANIMAL EXPERIMENT; APNEA; ARTICLE; BREATHING; BREATHING PATTERN; CONTROLLED STUDY; HUMAN; IMMATURITY; MOUSE; PRIORITY JOURNAL; RESPIRATION DEPRESSION;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; APNEA; CATS; DIZOCILPINE MALEATE; DRUG SYNERGISM; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MICE; PLETHYSMOGRAPHY; PULMONARY VENTILATION; QUINOXALINES; RECEPTORS, GLUTAMATE; SPECIES SPECIFICITY;

EID: 0032496086     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00160-5     Document Type: Article

References (41)

1. Abrahams T.P., Taveira DaSilva A.M., Hamosh P., McManigle J.E., Gillis R.A. Cardiorespiratory effects produced by blockade of excitatory amino acid receptors in cats. Eur. J. Pharmacol. 238:1993;223-233.
2. Ballanyi K., Völker A., Richter D.W. Functional relevance of anaerobic metabolism in the isolated respiratory network of newborn rats. Pflüg. Arch. 432:1996;741-748.
3. Bartlett D. Jr., Tenney S.M. Control of breathing in experimental anemia. Respir. Physiol. 10:1970;384-395.
4. Berger I., Gillis R.A., Vitagliano S., Panico W.H., Magee S., Kelly M., Norman W.P., McManigle J.E., Taveira DaSilva A.M. NMDA receptors are involved at the ventrolateral nucleus tractus solitarii for termination of inspiration. Eur. J. Pharmacol. 277:1995;195-208.
5. Bianchi A., Champagnat J., Denavit-Saubié M. Central control of breathing in mammals: neuronal circuitry, membrane properties, and neurotransmitters. Physiol. Rev. 75:1995;1-45.
6. Böhmer G., Schmid K., Schauer W. Evidence for an involvement of NMDA and non-NMDA receptors in synaptic excitation of phrenic motoneurons in the rabbit. Neurosci. Lett. 130:1991;271-274.
7. Bonham A.C. Neurotransmitters in the CNS control of breathing. Respir. Physiol. 101:1995;219-230.
8. Bonham A.C., Coles S.K., McCrimmon D.R. Pulmonary stretch receptor afferents activate excitatory amino acid receptors in the nucleus tractus solitarii in rats. J. Physiol. 464:1993;725-745.
9. Cassus-Soulanis S., Foutz A.S., Denavit-Saubié M. Involvement of NMDA receptors in inspiratory termination in rodents: effects of wakefulness. Brain Res. 679:1995;25-33.
10. Chapman A.G., Smith S.E., Meldrum B.S. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Res. 9:1991;92-96.
11. Connelly C.A., Otto-Smith M.R., Feldman J.L. Blockade of NMDA receptor-channels by MK-801 alters breathing in adult rats. Brain Res. 596:1992;99-110.
12. Dalgaard L., Hjortkjær K., Regnier B., Nordholm L. Pharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(F)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid. Drug Metab. Dispos. 22:1994;289-293.
13. Dall V., Ørntoft U., Schmidt A., Nordholm L. Interaction of the competitive AMPA receptor antagonist NBQX with hexobarbital. Pharmacol. Biochem. Behav. 46:1993;73-76.
14. Denavit-Saubié, M., Foutz, A.S., 1996. Neuropharmacology of respiration. In: Miller, A.D., Bianchi, A.L., Bishop, B.P. (Eds.), Neural Control of the Respiratory Muscles. CRC Press, New York, pp. 143-157.
15. Foutz A.S., Champagnat J., Denavit-Saubié M. N-methyl-D-aspartate (NMDA) receptors control respiratory off-switch in cat. Neurosci. Lett. 87:1988;221-226.
16. Foutz A.S., Champagnat J., Denavit-Saubié M. Respiratory effects of the N-methyl-D-aspartate (NMDA) antagonist, MK-801, in intact and vagotomized chronic cats. Eur. J. Pharmacol. 154:1988;179-184.
17. Foutz A.S., Champagnat J., Denavit-Saubié M. Involvement of N-methyl-D-aspartate (NMDA) receptors in respiratory rhythmogenesis. Brain Res. 500:1989;199-208.
18. Foutz A.S., Pierrefiche O., Denavit-Saubié M. Combined blockade of NMDA and non-NMDA receptors produces respiratory arrest in the adult cat. NeuroReport. 5:1994;481-484.
19. Fung M.-L., St John W.M. The functional expression of a pontine pneumotaxic centre in neonatal rats. J. Physiol. 489:1995;579-591.
20. Fung M.-L., Wang W., St John W.M. Involvement of pontile NMDA receptors in inspiratory termination in rat. Respir. Physiol. 96:1994;177-188.
21. Funk G.D., Smith J.C., Feldman J.L. Generation and transmission of respiratory oscillations in medullary slices: role of excitatory amino acids. J. Neurophysiol. 70:1993;1497-1515.
22. Gautier H., Bonora M., Gaudy J.H. Ventilatory response of the conscious or anesthetized cat to oxygen breathing. Respir. Physiol. 65:1986;181-196.
23. Gill R. The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 6:1994;225-256.
24. Gill R., Nordholm L., Lodge D. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Brain Res. 580:1992;35-43.
25. Greer J.J., Smith J.C., Feldman J.L. Role of excitatory amino acids in the generation and transmission of respiratory drive in neonatal rat. J. Physiol. 437:1991;727-749.
26. Hucker H.B., Hutt J.E., White S.D., Arison B.H., Zacchei A.G. Disposition and metabolism of (+) 5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine in rats, dogs and monkeys. Drug Metab. Dispos. 11:1983;54-58.
27. Lippert K., Welsch M., Krieglstein J. Over-additive protective effect of dizocilpine and NBQX against neuronal damage. Eur. J. Pharmacol. 253:1994;207-213.
28. Liu G., Feldman J.L., Smith J.C. Excitatory amino-acid-mediated transmission of inspiratory drive to phrenic motoneurons. J. Neurophysiol. 64:1990;423-436.
29. Löscher W., Rundfeldt C., Hönack D. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Eur. J. Neurosci. 5:1993;1545-1550.
30. McFarlane C., Warner D.S., Todd M.M., Nordholm L. AMPA receptor competitive antagonism reduced halothane MAC in rats. Anesthesiology. 77:1992;1165-1170.
31. McManigle J.E., Taveira Da Silva A.M., Dretchen K.L., Gillis R.A. Potentiation of MK-801-induced breathing impairment by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. Eur. J. Pharmacol. 252:1994;11-17.
32. Morin-Surun M.-P., Boudinot E., Kato F., Foutz A.S., Denavit-Saubié M. Involvement of NMDA receptors in the respiratory phase transition is different in the adult guinea pig in vivo and in the isolated brainstem preparation. J. Neurophysiol. 74:1995;770-778.
33. Mortola J.P., Noworaj A. Breathing and growth: comparative aspects. J. Comp. Physiol. B. 155:1985;155-171.
34. Nordholm L. Determination of the neuroprotective agent 6-nitro-7-sulfamoyl-benzo-(f)quinoxaline-2-,3-dione in plasma using high-performance liquid chromatography. J. Chromatogr. B. 568:1991;481-486.
35. Paton J.F.R., Richter D.W. Maturational changes in the respiratory rhythm generator of the mouse. Pflügers Arch. 430:1995;115-124.
36. Pierrefiche O., Schmid K., Foutz A.S., Denavit-Saubié M. Endogenous activation of NMDA and non-NMDA glutamate receptors on respiratory neurones in cat medulla. Neuropharmacology. 30:1991;429-440.
37. Pierrefiche O., Foutz A.S., Champagnat J., Denavit-Saubié M. The bulbar network of respiratory neurons during apneusis induced by a blockade of NMDA receptors. Exp. Brain Res. 8:1992;623-639.
38. Pierrefiche O., Foutz A.S., Champagnat J., Denavit-Saubié M. NMDA and non-NMDA receptors may play distinct roles in timing mechanisms and transmission in the feline respiratory network. J. Physiol. 474:1994;509-523.
39. Sheardown M.J., Nielsen E.Ø., Hansen A.J., Jacobsen P., Honoré T. 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science. 247:1990;571-574.
40. Swedberg M.D.B., Jacobsen P., Honoré T. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX). J. Pharmacol. Exp. Ther. 274:1995;1113-1121.
41. Wong E.H.F., Kemp J.A., Priestly T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;7104-7108.